CMR Prognostic Markers in Ischemic Heart Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CMR Prognostic Markers in Ischemic Heart Disease — Stella

Home/Ischemic Heart Disease (IHD)/

View on ClinicalTrials.gov

Recruiting

Back to Ischemic Heart Disease (IHD) trials

Trial locations(1 site)

China

Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing Municipality

Key details

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Collaborators

National Natural Science Foundation of China, Beijing Natural Science Foundation

Enrollment target

~1,000 participants

Started

January 2009

Primary completion

December 2035

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.